Explore the Potential with AI-Driven Innovation
This comprehensive focused library is produced on demand with state-of-the-art virtual screening and parameter assessment technology driven by Receptor.AI drug discovery platform. This approach outperforms traditional methods and provides higher-quality compounds with superior activity, selectivity and safety.
Our selection of compounds is from a large virtual library of over 60 billion molecules. The production and distribution of these compounds are managed by our partner Reaxense.
In the library, a selection of top modulators is provided, each marked with 38 ADME-Tox and 32 parameters related to physicochemical properties and drug-likeness. Also, every compound comes with its best docking poses, affinity scores, and activity scores, providing a comprehensive overview.
We employ our advanced, specialised process to create targeted libraries.
Fig. 1. The sreening workflow of Receptor.AI
Our methodology leverages molecular simulations to examine a vast array of proteins, capturing their dynamics in both isolated forms and in complexes with other proteins. Through ensemble virtual screening, we thoroughly account for the protein's conformational mobility, identifying critical binding sites within functional regions and distant allosteric locations. This detailed exploration ensures that we comprehensively assess every possible mechanism of action, with the objective of identifying novel therapeutic targets and lead compounds that span a wide spectrum of biological functions.
Key features that set our library apart include:
partner
Reaxense
upacc
Q96JI7
UPID:
SPTCS_HUMAN
Alternative names:
Colorectal carcinoma-associated protein; Spastic paraplegia 11 protein
Alternative UPACC:
Q96JI7; A8KAX9; B9EK60; F5H3N6; Q4VC11; Q58G86; Q69YG6; Q6NW01; Q8N270; Q8TBU9; Q9H734
Background:
Spatacsin, also known as Colorectal carcinoma-associated protein and Spastic paraplegia 11 protein, plays a crucial role in neurite plasticity. It maintains cytoskeleton stability and regulates synaptic vesicle transport, essential for proper neuronal function.
Therapeutic significance:
Spatacsin's involvement in diseases such as Spastic paraplegia 11, Amyotrophic lateral sclerosis 5, and Charcot-Marie-Tooth disease, highlights its potential as a target for therapeutic strategies. Understanding its role could lead to breakthroughs in treating these neurodegenerative disorders.